Cyclooxygenase2 expression in nonmetastatic triplenegative breast cancer patients

Author：

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.2, Iss.5, 2014-01, pp. : 845-850

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical characteristics and prognostic analysis of triplenegative breast cancer patients

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 245-251

Spandidos Publications

Access to resources Recommend Favorite

Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer

Current Molecular Medicine, Vol. 13, Iss. 3, 2013-03 ,pp. : 410-416

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclooxygenase-2 and its role in colorectal cancer development

By Wendum Dominique

Virchows Archiv, Vol. 445, Iss. 4, 2004-10 ,pp. : 327-333

Springer Publishing Company

Access to resources Recommend Favorite

Cyclooxygenase-2 Inhibitor Treatment of Older Osteoarthritis Patients

By Andersen Sara Jane

Comprehensive Therapy, Vol. 29, Iss. 4, 2003-12 ,pp. : 215-223

Humana Press, Inc

Access to resources Recommend Favorite

Metastatic breast cancer in patients with schizophrenia

By Meyer Aaron A.

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 359-364

Spandidos Publications

Access to resources Recommend Favorite